BR Biopharma, Inc. (NASDAQ:BRBI – Get Free Report) declared a quarterly dividend on Friday, August 7th. Shareholders of record on Monday, August 17th will be given a dividend of 0.1415 per share on Friday, September 4th. This represents a c) annualized dividend and a yield of 6.0%. The ex-dividend date is Monday, August 17th.
BR Biopharma Trading Up 0.5%
Shares of BRBI stock opened at $9.40 on Friday. The company’s 50-day moving average price is $11.32. BR Biopharma has a 12 month low of $9.23 and a 12 month high of $67.01.
BR Biopharma (NASDAQ:BRBI – Get Free Report) last released its quarterly earnings results on Tuesday, June 30th. The company reported $0.09 earnings per share for the quarter. The firm had revenue of $25.13 million for the quarter.
BR Biopharma Company Profile
BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.
See Also
- Five stocks we like better than BR Biopharma
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
- AirJoule Technologies: Short Squeeze Setup Amid Rising Risks
- MarketBeat Week in Review – 08/10 – 08/14
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
Receive News & Ratings for BR Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BR Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
